Evidence map›Paper›PMID 34676011›Full record

ArticlePaediatrics & child health2021

Newly approved IV acetaminophen in Canada: Switching from oral to IV acetaminophen. Is IV worth the price difference? A systematic review.

Maxime Ulrich, Martine Chamberland, Christel Bertoldi, Facundo Garcia-Bournissen, Niina Kleiber

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Paediatrics & child health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05557344 (Oral Versus Intravenous Acetaminophen for the Treatment of Pain Secondary to Long Bone Fracture Requiring Surgery in Children), which is not on this map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05557344 phase4unknown statusnot on this map

Oral Versus Intravenous Acetaminophen for the Treatment of Pain Secondary to Long Bone Fracture Requiring Surgery in Children

TypeinterventionalSponsorDr. Niina KleiberRan2021 to 2024Enrolled20ConditionsPainArmsAcetaminophen IV, Acetaminophen
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Maxime UlrichFaculty of Medicine, Université de Montréal, Montreal, Quebec.
Martine ChamberlandFaculty of Medicine, Université de Montréal, Montreal, Quebec.
Christel BertoldiCHU Sainte-Justine Université de Montréal, Montreal, Quebec.
Facundo Garcia-BournissenDivision of Paediatric Clinical Pharmacology, Department of Paediatrics, Schulich School of Medicine and Dentistry, Western University, London, Ontario.
Niina KleiberDepartment of Pharmacology and Physiology, Université de Montréal, Montreal, Quebec.
Université de Montréal · CACentre Hospitalier Universitaire Sainte-Justine · CAUniversité de Sherbrooke · CAWestern University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextThe use of intravenous acetaminophen leads to meaningful health cost increases for paediatric institutions. Therefore, strict criteria for intravenous acetaminophen administration are needed.

objectiveTo undertake a systematic review of available evidence comparing oral versus intravenous acetaminophen use in children.

methodA systematic literature search was conducted on five databases. All prospective interventional studies comparing intravenous to oral acetaminophen in patients <18 years old were included. Data collection and analysis were done according to PRISMA guidelines.

resultsAmong 6,417 retrieved abstracts, 29 full-text articles were assessed of which 3 were retained. (1)

conclusionsAvailable data are insufficient to guide clinicians with a rational choice of route of administration. Oral bioavailability should be studied in paediatric populations outside the intensive care unit. Despite the widespread use of intravenous acetaminophen, there is little evidence to suggest that it improves analgesia compared to the oral formulation. Similarly, fever weans faster but whether this translates into any meaningful clinical outcome is unknown. The lack of data plus the significantly higher costs of intravenous acetaminophen should motivate further research.

Indexed as

AcetaminophenFeverPaediatricsPainParacetamolPharmacokinetic

Identifiers

PMID34676011
PMCPMC8522831
OpenAlexW3139314105

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.